# OnCo record pcwg3 (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/pcwg3/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "pcwg3" ;
  schema:name "PCWG3 (Prostate Cancer Clinical Trials Working Group 3)"@en ;
  schema:alternateName "PCWG3"@en, "PCWG2"@en, "Prostate Cancer Working Group 3"@en, "Prostate Cancer Clinical Trials Working Group 3"@en, "no longer clinically benefiting"@en ;
  schema:description "PCWG3 is the set of rules most prostate cancer trials use to decide when the cancer has progressed on PSA blood tests and scans, and it separates the first sign of progression from the point when treatment should change."@en ;
  schema:url <https://onco.cc/terms/pcwg3/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.2015.64.2702> ;
  onco:related <https://onco.cc/terms/psa50/>, <https://onco.cc/terms/psa/>, <https://onco.cc/terms/recip-1/>, <https://onco.cc/terms/recist/>, <https://onco.cc/terms/met-rads-p/> ;
  onco:cancers <https://onco.cc/cancers/prostate/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-scher-j-clin-oncol/> .